Answers are grounded in this paper and cite their sources.
Discovery of new acetylcholinesterase inhibitors from quinazolinones shows significant inhibitory activity, with implications for neurological research.
In the present study, twelve quinazolinones ( 2, 3, 4a–4j ) were successfully synthesized. Among them, five compounds ( 4c, 4d, 4f, 4h, 4i ) were newly reported. Furthermore, twelve compounds were assessed against acetylcholinesterase (AChE). Seven compounds ( 4b, 4c, 4d, 4f, 4g, 4h, 4j ) showed inhibitory activity above 70%, where compounds 4c and 4h had inhibitory activity with IC₅₀ values of 2.97 and 5.86 μM, respectively. The kinetic study showed that compounds 4c and 4h exhibited mixed-type inhibition. Molecular docking suggested that compounds 4c and 4h displayed binding energy values of −8.7 and −8.4 kcal/mol. Compound 4c showed H-bonds with four residues (Tyr124, Tyr337, Tyr341, and Glu202), but compound 4h formed H-bonds with three residues (Tyr124, Tyr133, and Glu202) in the binding pocket of AChE. Thus, quinazolinone derivatives with a nitro group at the C-6 and alkoxy groups at the C-7 position have the potential for further investigation as AChE inhibitors.
No takes yet. Share an insight, caveat, or question.
Danova et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: